| MED.00110 Silver-based Products for Wound and Soft Tissue Applications | MED.00110 · Commercial | 1 | Original policy ↗ |
| MED.00111 Intracardiac Ischemia Monitoring | MED.00111 · Commercial | 9 | Original policy ↗ |
| MED.00116 Near-Infrared Spectroscopy Scanning for Brain Hematoma Screening | MED.00116 · Commercial | 1 | Original policy ↗ |
| MED.00118 Continuous Monitoring of Intraocular Pressure | MED.00118 · Commercial | 1 | Original policy ↗ |
| MED.00120 Gene Therapy for Ocular Conditions | MED.00120 · Commercial | 5 | Original policy ↗ |
| MED.00129 Gene Therapy for Spinal Muscular Atrophy | MED.00129 · Commercial | 2 | Original policy ↗ |
| MED.00130 Surface Electromyography and Electrodermal Activity Sensor Devices for Seizure Monitoring | MED.00130 · Commercial | 3 | Original policy ↗ |
| MED.00131 Electronic Home Visual Field Monitoring | MED.00131 · Commercial | 2 | Original policy ↗ |
| MED.00132 Autologous Adipose-derived Regenerative Cell Therapy | MED.00132 · Commercial | 8 | Original policy ↗ |
| MED.00133 Ingestion Event Monitors | MED.00133 · Commercial | 2 | Original policy ↗ |
| MED.00135 Gene Therapy for Hemophilia | MED.00135 · Commercial | 6 | Original policy ↗ |
| MED.00137 Eye Movement Analysis Using Non-spatial Calibration for the Diagnosis of Concussion | MED.00137 · Commercial | 1 | Original policy ↗ |
| MED.00138 Wearable Devices for Stress Relief and Management | MED.00138 · Commercial | 2 | Original policy ↗ |
| MED.00139 Electrical Impedance Scanning for Cancer Detection | MED.00139 · Commercial | 1 | Original policy ↗ |
| MED.00140 Gene Therapy for Beta Thalassemia | MED.00140 · Commercial | 5 | Original policy ↗ |
| MED.00142 Gene Therapy for Cerebral Adrenoleukodystrophy | MED.00142 · Commercial | 4 | Original policy ↗ |
| MED.00143 Ingestible Devices for the Treatment of Constipation | MED.00143 · Commercial | 2 | Original policy ↗ |
| MED.00146 Gene Therapy for Sickle Cell Disease | MED.00146 · Commercial | 5 | Original policy ↗ |
| MED.00148 Gene Therapy for Metachromatic Leukodystrophy | MED.00148 · Commercial | 4 | Original policy ↗ |
| MED.00150 Hepzato Kit™ (melphalan hepatic delivery system) | MED.00150 · Commercial | 2 | Original policy ↗ |
| MED.00151 Gene Therapy for Aromatic L-Amino Acid Decarboxylase Deficiency | MED.00151 · Commercial | 4 | Original policy ↗ |
| MED.00152 Outpatient Intravenous Insulin Therapy | MED.00152 · Commercial | 1 | Original policy ↗ |
| Medicare Advantage 2017 Precertification Requirements | Effective Jan 1, 2017 · CA, CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, VA, WI | 132 | Original policy ↗ |
| Medicare Advantage 2018 Precertification Requirements | Effective Jan 1, 2018 · CA, CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, VA, WI | 158 | Original policy ↗ |
| Medicare Advantage Precertification Requirements – 2019 | CA, CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, VA, WI | 191 | Original policy ↗ |
| Medicare Advantage Provider Manual | MULTI-BCBS-CR-PM-008700-26-GRP2620 · Effective Apr 1, 2026 · CO, CT, GA, IN, KY, ME, MO, NH, NV, NY, OH, WI | — | Original policy ↗ |
| Medicare Supplement System Consolidation FAQs | 59396MUPENMUB · Commercial · IN, KY, MO, OH, WI | — | Original policy ↗ |
| MISSOURI PROVIDER MANUAL | Commercial · MO | 23 | Original policy ↗ |
| MISSOURI PROVIDER MANUAL | Commercial · MO | 23 | Original policy ↗ |
| MISSOURI PROVIDER MANUAL | Commercial · MO | 2 | Original policy ↗ |
| Missouri Provider Manual | MOBCBS-CM-PM-087497-25 · Effective Jan 1, 2026 · Commercial · MO | 24 | Original policy ↗ |
| Moderate (Conscious) Sedation – Professional and Facility | C-25001 · Effective Oct 1, 2025 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | 6 | Original policy ↗ |
| Modifier 22 – Professional | C-12003 · Effective May 6, 2025 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Modifier 62 – Professional | C-21005 · Effective Nov 17, 2023 · Commercial · CO, CT, GA, IN, KY, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Modifier 66 – Professional | C-21006 · Effective Nov 17, 2023 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Modifier FB – Professional and Facility | C-22003 · Effective Oct 1, 2022 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Modifier Usage - Facility | C-23005 · Effective Apr 1, 2026 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Modifier Usage – Professional | C-08010 · Effective Jun 3, 2025 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | 12 | Original policy ↗ |
| Modifiers 25 and 57: Evaluation and Management with Global Procedures | C-09011 · Effective Nov 23, 2022 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | 8 | Original policy ↗ |
| Modifiers 26 and TC: Professional and Technical Component - Professional | C-20004 · Effective Dec 2, 2025 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Modifiers 50 and 51: Multiple and Bilateral Surgery - Professional | C-08004 · Effective Oct 30, 2023 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | 63 | Original policy ↗ |
| Modifiers 59 and XE, XP, XS, and XU: Distinct Procedural Service - Professional | C-09006 · Effective Mar 15, 2026 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | 187 | Original policy ↗ |
| Modifiers 80, 81, 82 and AS: Assistant at Surgery - Professional | C-08006 · Effective Sep 27, 2023 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | 44 | Original policy ↗ |
| Modifiers 90, 91, and 92: Laboratory Services – Professional and Facility | C-26002 · Effective Nov 1, 2026 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | 6 | Original policy ↗ |
| Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy | LAB.00042 · Commercial | 1 | Original policy ↗ |
| MRI Guided High Intensity Focused Ultrasound Ablation for Non-Oncologic Indications | MED.00057 · Commercial | 6 | Original policy ↗ |
| Multiple Delivery Services – Professional | C-19005 · Effective Apr 29, 2022 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Multiple Diagnostic Imaging Procedures – Professional and Facility | C-25003 · Effective Oct 26, 2025 · Commercial · CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Multiple Procedure Payment Reduction – Professional | C-23003 · Effective Apr 12, 2023 · Commercial · CO, CT, GA, IN, KY, MO, NH, NV, OH, WI | — | Original policy ↗ |
| Multiple Surgery – Facility | C-21004 · Effective Jan 1, 2022 · Commercial · CO, CT, GA, IN, KY, MO, NV, OH | — | Original policy ↗ |
